InvestSMART

ImpediMed Limited (ASX:IPD)

ALERT: Price-sensitive ASX Announcement for IPD
Current share price for IPD : $0.006 0 (0%)+
Announcement
Release
10 Jun 2026 9:05AM
Price at Release
$0.006
Full Release
download
Summary
ImpediMed Limited announced the successful completion of its oversubscribed Share Purchase Plan (SPP), raising $2.1 million. This follows a $13.2 million institutional placement. The SPP closed on June 5, 2026, and allowed eligible shareholders in Australia and New Zealand to apply for up to $100,000 of new fully paid ordinary shares without incurring additional costs. The Board accepted oversubscriptions of up to an additional A$0.1 million, increasing the total capital raised under the SPP to A$2.1 million. SPP shares are to be issued at $0.007 per share, with participants receiving one Attaching Option and one Follow-on Option per share. These transactions are subject to shareholder approval at a general meeting scheduled for June 11, 2026, with trading on the ASX expected to commence on June 16, 2026.
Key Points
  • Successful completion of oversubscribed Share Purchase Plan (SPP).
  • A total of $2.1 million raised through SPP after $13.2 million institutional placement.
  • SPP closed on June 5, 2026, with oversubscriptions accepted.
  • Shareholders in Australia and New Zealand could apply for up to $100,000 of shares.
  • SPP issue price set at $0.007 per share, a 2.5% discount to the 5-day VWAP.
  • 300 million SPP shares to be issued, with attaching and follow-on options.
  • Subject to shareholder approval at the EGM on June 11, 2026.
  • Trading on the ASX expected to begin on June 16, 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.